APTARGROUP, INC.ATREarnings & Financial Report
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
Revenue
$910.1M
Gross Profit
N/A
Operating Profit
$126.0M
Net Profit
$90.5M
Gross Margin
N/A
Operating Margin
13.8%
Net Margin
9.9%
YoY Growth
1.6%
EPS
$1.34
APTARGROUP, INC. Q2 FY2024 Financial Summary
APTARGROUP, INC. reported revenue of $910.1M (up 1.6% YoY) for Q2 FY2024, with a net profit of $90.5M (up 8.9% YoY) (9.9% margin).
Key Financial Metrics
| Total Revenue | $910.1M |
|---|---|
| Net Profit | $90.5M |
| Gross Margin | N/A |
| Operating Margin | 13.8% |
| Report Period | Q2 FY2024 |
Revenue Breakdown
APTARGROUP, INC. Q2 FY2024 revenue of $910.1M breaks down across 4 segments, led by Other at $459.9M (50.5% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Other | $459.9M | 50.5% |
| Aptar Pharma | $207.5M | 22.8% |
| Aptar Beauty | $190.7M | 21.0% |
| Aptar Closures | $51.9M | 5.7% |
APTARGROUP, INC. Revenue by Segment — Quarterly Trend
APTARGROUP, INC. revenue by segment across the last 4 reported quarters, showing how each business line (such as Other and Aptar Pharma) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Other | — | $129.6M | $495.3M | $490.0M |
| Aptar Pharma | — | — | $208.1M | $211.8M |
| Aptar Beauty | — | — | $196.1M | $205.2M |
| Aptar Closures | — | — | $61.6M | $58.9M |
APTARGROUP, INC. Annual Revenue by Year
APTARGROUP, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $3.8B).
| Year | Annual Revenue |
|---|---|
| 2025 | $3.8B |
| 2024 | $3.6B |
| 2023 | $3.5B |
| 2022 | $3.3B |
APTARGROUP, INC. Quarterly Revenue & Net Profit History
APTARGROUP, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $982.9M | +10.8% | $72.8M | 7.4% |
| Q4 FY2025 | $962.7M | +13.5% | $74.3M | 7.7% |
| Q3 FY2025 | $961.1M | +5.7% | $127.9M | 13.3% |
| Q2 FY2025 | $966.0M | +6.1% | $111.7M | 11.6% |
| Q1 FY2025 | $887.3M | -3.1% | $78.8M | 8.9% |
| Q4 FY2024 | $848.1M | +1.1% | $100.9M | 11.9% |
| Q3 FY2024 | $909.3M | +1.8% | $100.0M | 11.0% |
| Q2 FY2024 | $910.1M | +1.6% | $90.5M | 9.9% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $910.1M | $909.3M | $848.1M | $887.3M | $966.0M | $961.1M | $962.7M | $982.9M |
| YoY Growth | 1.6% | 1.8% | 1.1% | -3.1% | 6.1% | 5.7% | 13.5% | 10.8% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $4.45B | $4.63B | $4.43B | $4.53B | $4.87B | $5.10B | $5.25B | $5.10B |
| Liabilities | $2.06B | $2.09B | $1.96B | $1.99B | $2.17B | $2.33B | $2.58B | $2.42B |
| Equity | $2.40B | $2.54B | $2.47B | $2.54B | $2.70B | $2.77B | $2.67B | $2.65B |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $143.6M | $229.3M | $178.2M | $82.7M | $126.0M | $177.6M | $183.7M |